DOCSLIB.ORG

Generated by SRI International Pathway Tools Version 25.0 on Sat

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Generated by SRI International Pathway Tools Version 25.0 on Sat Authors: Pallavi Subhraveti Ron Caspi Peter Midford Peter D Karp An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Ingrid Keseler Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_000754405Cyc: Flavobacterium psychrophilum FPG3 Cellular Overview Connections between pathways are omitted for legibility. Anamika Kothari phosphate phosphate phosphate phosphate predicted ABC RS10325 RS01900 transporter RS10755 of phosphate phosphate phosphate phosphate phosphate Fatty Acid and Metabolic Regulator Lipid Degradation Carbohydrate Biosynthesis Degradation ditrans,octacis- a peptidoglycan with a nascent a [bis(guanylyl a peptidoglycan oleate β-oxidation a purine an N-modified an L-asparaginyl- an L-cysteinyl- [2Fe-2S] iron-sulfur Cofactor, Carrier, and Vitamin Biosynthesis undecaprenyldiphospho- (L-alanyl-γ-D-glutamyl- adenosylcobinamide peptidoglycan molybdopterin) cys dimer (meso- superpathway of tetrahydrofolate biosynthesis superpathway of coenzyme A biosynthesis I (bacteria) NAD de novo biosynthesis adenosylcobinamide-GDP thiamine diphosphate ppGpp metabolism D-mannose ribonucleoside aminoacyl-[tRNA] [tRNA Asn ] [tRNA Cys ] dGDP cluster biosynthesis thiamine diphosphate TCA cycle TCA cycle I (prokaryotic) N-acetyl-(N-acetyl-β-D- L-lysyl-D-alanyl-D- (meso-DAP cofactor diaminopimelate II (from tryptophan) salvage from cobinamide I biosynthesis III biosynthesis II (Bacillus) oleate degradation alanine) pentapeptide 5'-triphosphate chaperone]- containing) ribonucleoside- 3-methyl-2- a 5,10- glucosaminyl)muramoyl- containing) (Staphylococcus) γ diphosphate L-cysteine desulfurase cob(II)inamide pppGpp acetyl-CoA D-mannopyranose L-alanyl- -D-glutamyl-L- L-cysteine aminoacyl- aminoacyl- aminoacyl- GTP oxobutanoate methylenetetrahydrofolate HMP-PP trp long-chain fatty bifunctional reductase cob(I)yrinic acid HMP-PP 6-phosphate lysyl-D-alanyl-D-alanine tRNA penicillin- tRNA tRNA thiamine tryptophan 2,3- bifunctional (p)ppGpp acid--CoA ligase: class I mannose- adenosylcobinamide lytic subunit alpha: cysteine 3-methyl-2-oxobutanoate a,c-diamide thiamine menaquinol-7 biosynthesis hydrolase: binding hydrolase: hydrolase: GTP phosphate dioxygenase: synthetase/guanosine- oxaloacetate FPG3_RS09065 6-phosphate kinase/ transglycosylase cysteine FPG3_RS02335 desulfurase: hydroxymethyltransferase: adenosyltransferase: phosphate guanosine 3'- arfB protein arfB arfB cyclohydrolase synthase: FPG3_RS01205 all-trans- 3',5'-bis(diphosphate) 3'- isomerase: monofunctional adenosylcobinamide- domain-containing desulfurase: FPG3_RS11525 panB N-Formyl-L- FPG3_RS05140 synthase: diphosphate 5'- citrate synthase: 2: mrdA ribonucleoside- I FolE: folE FPG3_RS02195 [corrinoid heptaprenyl 1,4-dihydroxy- pyrophosphohydrolase: oleoyl-CoA FPG3_RS08730 biosynthetic phosphate protein: FPG3_RS05750 aminoacyl-tRNA aminoacyl-tRNA aminoacyl-tRNA cysteine kynurenine FPG3_RS02195 triphosphate 3'- malate:quinone FPG3_RS02855 diphosphate asp adenosyltranferase]- diphosphate 2-naphthoate FPG3_RS08340 F6P peptidoglycan guanylyltransferase: FPG3_RS07600 cysteine hydrolase: hydrolase: hydrolase: desulfurase: GTP thiamine thiamine diphosphatase: oxidoreductase: acyl-CoA reductase: cob(II)inamide transglycosylase: cobU endolytic desulfurase: FPG3_RS01215 a peptidoglycan FPG3_RS01215 FPG3_RS01215 FPG3_RS05750 cyclohydrolase 2-dehydropantoate phosphate FPG3_RS08340 FPG3_RS08905 dehydrogenase: FPG3_RS02340 aspartate 1- phosphate malate dehydrogenase: mtgA transglycosylase FPG3_RS11525 with D,D cross- D-ala I FolE: folE synthase: synthase: FPG3_RS03425 adenosyl- GDP an S-sulfanyl-[L- 7,8- decarboxylase: FPG3_RS04900 MltG: mltG links (meso- FPG3_RS02205 FPG3_RS02205 [+ 3 isozymes] cobinamide an N-modified an uncharged cysteine desulfurase] dihydroneopterin flavin biosynthesis I (bacteria and plants) FPG3_RS00585 thiamine L-kynurenine [corrinoid Secondary Metabolite Degradation a peptidoglycan with di-trans,octa-cis a purine a [bis(guanylyl diaminopimelate asn tRNA Asn cys a tRNA Cys thiamine demethylmenaquinol-7 GTP ppGpp (S)-malate citrate phosphate tRNA phosphate adenosyltranferase]- (2E,9Z)- (L-alanyl-γ-D-glutamyl- -undecaprenyl amino acid containing) 3'-triphosphate β phosphate ribonucleoside a mature a nascent ala molybdopterin) -alanine kynurenine 3- octadecenoyl-CoA diphosphate (R)-pantoate thiamine- cob(I)inamide bifunctional anhydromuropeptides recycling I L-lysyl-D-alanyl-D- 5'-diphosphate peptidoglycan peptidoglycan cofactor monooxygenase: GTP phosphate cob(I)yrinic acid demethylmenaquinone nucleoside- alanine) pentapeptide with (L-alanyl- (meso-DAP chaperone]-S- an S-sulfanyl-[cysteine FPG3_RS10790 fumarate hydratase: 7,8- pantoate--beta- kinase: thiL a,c-diamide methyltransferase/2- diphosphate GDP aconitate hydratase: GlcNAc-1,6- γ-D-glutamyl- containing) with sulfanyl-L-cysteine desulfurase]-[disordered- adenosyltransferase: kinase: pyrophosphokinase: bifunctional (p)ppGpp FPG3_RS08565 dihydroneopterin GTP alanine ligase: thiamine 3-hydroxy- thiamine methoxy-6-polyprenyl- FPG3_RS03555 (S)-3-hydroxy-(9Z) anhMurNAc- meso-2,6- GlcNAc terminus form scaffold FPG3_RS04585 synthetase/guanosine- γ 3'-phosphate cyclohydrolase FPG3_RS00590 L-kynurenine FPG3_RS05140 1,4-benzoquinol FPG3_RS08340 class II fumarate -octadecenoyl-CoA L-Ala- -D-Glu- diaminopimeloyl- protein] complex diphosphate 3',5'-bis(diphosphate) 3'- [cysteine desulfurase]-S- II: ribB thiamine methylase UbiE: ubiE hydratase: fumC DAP-D-Ala D-alanine) 2,5-diamino-6- kynureninase: adenosylcobinamide pyrophosphohydrolase: fumarate cis-aconitate 3-hydroxyacyl-CoA sulfanylcysteine:[acceptor diphosphokinase: dehydrogenase: tetrapeptide (5-phospho-D- (R)-pantothenate kynU menaquinol-7 FPG3_RS08340 aconitate hydratase: protein]-cysteine bifunctional FPG3_RS08835 FPG3_RS10310 D-erythro-7,8- chorismate ribosylamino) superpathway of thiamine diphosphate biosynthesis I GDP succinate dehydrogenase/ FPG3_RS03555 sulfurtransferase: pyrimidin- type III 3-hydroxyanthranilate adenosylcobinamide thiamine fumarate reductase 3-oxo-(9Z)- dihydroneopterin N-acetyl-β-D- L-alanyl-γ-D- UDP-N-acetyl-α-D-muramoyl- ditrans,octacis- a peptidoglycan a ribonucleoside a [protein] FPG3_RS05750 pantothenate kinase/ diphosphate D-alanyl-D-alanine an adenine in DNA a D-tyrosyl- aminodeoxychorismate/ 4(3H)-one iron-sulfur subunit: octadecenoyl-CoA γ a malonyl-[acp] a palmitoleoyl-[acp] undecaprenyldiphospho- dimer (generic) Tyr C-terminal glu a [cysteine desulfurase]- dihydroneopterin cys 3-hydroxyanthranilate glucosamine-1,6- glutamyl-meso-2,6- L-alanyl- -D-glutamyl-L-lysine diphosphate [tRNA ] dADP anthranilate synthase bifunctional kinase: adenosylcobinamide- FPG3_RS00510 acetyl-CoA C- N-acetyl-(N- type I restriction- L-glutamate S-sulfanyl-[disordered- aldolase: folB 3,4-dioxygenase: anhydro-N-acetyl- diaminopimeloyl- ribonucleoside- component II: diaminohydroxyphosphoribosylaminopyrimidine FPG3_RS11750 phosphate acyltransferase: β acetylglucosaminyl) modification ribonucleoside- form scaffold cysteine FPG3_RS10905 -D-muramate D-alanine lytic diphosphate 6-(hydroxymethyl) FPG3_RS04820 deaminase/5-amino-6-(5-phosphoribosylamino) (R)-4'- guanylyltransferase: succinate FPG3_RS09040 bifunctional UDP- muramoyl-L-alanyl-γ- system subunit M: diphosphate protein] complex desulfurase: 2-amino-3- Secondary Metabolite Biosynthesis D-threo-isocitrate glcNAc-1,6- LD- beta- transglycosylase reductase D-tyrosyl- 30S cysteine -7,8-dihydropterin uracil reductase RibD: ribD cobU N-acetylmuramoyl- β FPG3_RS04735 reductase 4-amino-4- phosphopantothenate carboxymuconate- isocitrate dehydrogenase acetyl-CoA C- anhMurNAcaminidase: carboxypeptidase: ketoacyl- D-isoglutaminyl-N-( - domain-containing subunit alpha: tRNA(Tyr) ribosomal desulfurase: 5-amino-6-(5- FPG3_RS11525 ADP-forming tripeptide:D-alanyl-D- subunit alpha: 2-amino-4-hydroxy-6- deoxychorismate bifunctional adenosyl-cobinamide (NADP(+)): FPG3_RS08310 acyltransferase: FPG3_RS05985 FPG3_RS00335 ACP D-asparaginyl)-L-lysyl- Dam family site- FPG3_RS02335 deacylase: phospho-D- cysteine 6-semialdehyde fluoroacetate and alanine ligase/alanine protein: protein FPG3_RS02335 FPG3_RS11525 hydroxymethyldihydropteridine phosphopantothenoylcysteine phosphate pyridoxal 5'-phosphate biosynthesis I preQ biosynthesis succinate--CoA ligase synthase D-alanyl-D-alanine specific DNA- FPG3_RS01305 0 FPG3_RS06045 1,6-anhydro-N- LD- FPG3_RS07600 ribonucleoside- S6--L- cysteine diphosphokinase: folK ribosylamino)uracil desulfurase: fluorothreonine biosynthesis subunit beta: sucC racemase: FPG3_RS10640 (adenine-N6)- ribonucleoside- decarboxylase/ bifunctional acetyl-β-muramate carboxypeptidase: II: fabF diphosphate glutamate (7,8-dihydropterin- D-ribulose bifunctional FPG3_RS05750 D-erythrose (7Z)-hexadecenoyl-CoA UDP-N-acetylmuramoyl- endolytic fluoride RS08685 fluoride desulfurase: phosphopantothenate-- succinate--CoA ligase FPG3_RS01775 monofunctional methyltransferase: reductase: ligase: rimK diphosphate 6-yl)methyl 5-phosphate diaminohydroxyphosphoribosylaminopyrimidine an [L-cysteine adenosylcobinamide fluoride anhydro-N- transglycosylase FPG3_RS05750 cysteine ligase CoaBC: coaBC 4-phosphate subunit alpha: sucD L-alanyl-γ-D- tripeptide--D-alanyl- FPG3_RS06440 Tyr reductase:
Load more

Recommended publications
  • Enzyme-Catalyzed C–F Bond Formation and Cleavage
    Tong et al. Bioresour. Bioprocess. (2019) 6:46 https://doi.org/10.1186/s40643-019-0280-6 REVIEW Open Access Enzyme-catalyzed C–F bond formation and cleavage Wei Tong1,2 , Qun Huang1,2, Min Li1,2 and Jian‑bo Wang1,2* Abstract Organofuorines are widely used in a variety of applications, ranging from pharmaceuticals to pesticides and advanced materials. The widespread use of organofuorines also leads to its accumulation in the environment, and two major questions arise: how to synthesize and how to degrade this type of compound efectively? In contrast to a considerable number of easy‑access chemical methods, milder and more efective enzymatic methods remain to be developed. In this review, we present recent progress on enzyme‑catalyzed C–F bond formation and cleav‑ age, focused on describing C–F bond formation enabled by fuorinase and C–F bond cleavage catalyzed by oxidase, reductase, deaminase, and dehalogenase. Keywords: Organofuorines, C–F bonds, Enzyme‑catalyzed, Degradation, Formation Introduction usually require harsh conditions and are not environ- Incorporation of fuorine into organic compounds usu- ment friendly (Dillert et al. 2007; Lin et al. 2012; Sulbaek ally endows organofuorines with unique chemical and Andersen et al. 2005). To solve these problems, devel- physical properties, a strategy that has been successfully opment of mild and green methods is urgently needed. applied in agrochemicals, materials science, and pharma- Biocatalysis has been playing an increasingly more ceutical chemistry (Phelps 2004; Müller et al. 2007; Shah important role in modern chemistry due to its high ef- and Westwell 2007; Hagmann 2008; Nenajdenko et al.
    [Show full text]
  • Nouchali Bandaranayaka Phd Thesis
    Studies of enzymes relevant to the biotransformation of fluorinated natural products Nouchali Bandaranayaka Supervisor: Prof. David O’Hagan This thesis is submitted in partial fulfilment for the degree of PhD at the University of St Andrews NOVEMBER 2016 ii Declarations 1. Candidate’s declarations: I, Nouchali Bandaranayaka hereby certify that this thesis, which is approximately 50,000 words in length, has been written by me, and that it is the record of work carried out by me, or principally by myself in collaboration with others as acknowledged, and that it has not been submitted in any previous application for a higher degree. I was admitted as a research student in November 2009 and as a candidate for the degree of Doctor of Philosophy in November 2011; the higher study for which this is a record was carried out in the University of St Andrews between 2009 and 2016. Date Signature of candidate 2. Supervisor’s declaration: I hereby certify that the candidate has fulfilled the conditions of the Resolution and Regulations appropriate for the degree of Doctor of Philosophy in the University of St Andrews and that the candidate is qualified to submit this thesis in application for that degree. Date Signature of supervisor 3. Permission for publication: In submitting this thesis to the University of St Andrews I understand that I am giving permission for it to be made available for use in accordance with the regulations of the University Library for the time being in force, subject to any copyright vested in the work not being affected thereby.
    [Show full text]
  • Enzymatic Resolution of Α-Haloacids and Esters and Their Use in The
    Engineering of Candida antarctica lipase B for the kinetic resolution of α-halo esters A thesis submitted to the University of Manchester for the degree of Doctor of Philosophy in the Faculty of Engineering and Physical Sciences 2010 Shu-Ling Tang School of Chemistry Contents Contents 2 Abstract 6 Declaration 7 Copyright statement 8 Acknowledgements 9 Abbreviations 10 1 Introduction 12 1.1 Chirality in nature 12 1.2 Enantiomers of drugs 12 1.2.1 Chiral pool asymmetric synthesis 14 1.2.2 Resolution 15 1.2.3 Auxiliary controlled stereoselectivity 17 1.2.4 Reagent controlled stereoselectivity 18 1.3 Pharmacologically active compounds 19 1.3.1 Retrosynthetic analyses of (S)-Keppra and (R)-Tiopronin 19 1.3.2 (S)-Keppra 19 1.3.3 (R)-Tiopronin 23 1.3.4 Synthesis of other chiral starting materials from 2-bromoalkanoic acid 24 1.3.5 2-Fluoropropionic acid 25 1.4 Chemical synthesis of α-haloacids 26 1.4.1 Chemical synthesis of 2-bromopropionic acid 26 1.4.2 Chemical synthesis of enantiopure 2-bromopropionic acid 27 1.4.3 Chemical synthesis of 2-fluoropropionic acid 28 1.4.4 Chemical synthesis of enantiopure 2-fluoropropionic acid 31 1.5 Biocatalysis 31 1.5.1 Biocatalysts 32 1.5.2 Enzyme classes 32 1.5.3 Hydrolases (EC 3.X.X.X) 33 1.6 Biosynthesis of halogenated compounds 34 2 1.6.1 Haloperoxidases and perhydrolases 34 1.6.2 Flavin dependent halogenases 36 1.6.3 Fluorinase 37 1.7 Kinetic resolution of α-haloacids and ester using lipases 38 1.7.1 Kinetic resolution of α-haloacids 39 1.7.2 Kinetic resolution of α-haloesters 40 1.8 Directed evolution
    [Show full text]
  • Characterization of a SAM-Dependent Fluorinase from a Latent Biosynthetic Pathway for Fluoroacetate and 4-Fluorothreonine Format
    F1000Research 2014, 3:61 Last updated: 16 MAY 2019 RESEARCH ARTICLE Characterization of a SAM-dependent fluorinase from a latent biosynthetic pathway for fluoroacetate and 4-fluorothreonine formation in Nocardia brasiliensis [version 1; peer review: 2 approved] Yaya Wang, Zixin Deng , Xudong Qu Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan, 430071, China First published: 19 Feb 2014, 3:61 ( Open Peer Review v1 https://doi.org/10.12688/f1000research.3-61.v1) Latest published: 19 Feb 2014, 3:61 ( https://doi.org/10.12688/f1000research.3-61.v1) Reviewer Status Abstract Invited Reviewers Fluorination has been widely used in chemical synthesis, but is rare in 1 2 nature. The only known biological fluorination scope is represented by the fl pathway from Streptomyces cattleya that produces fluoroacetate (FAc) and version 1 4-fluorothreonine (4-FT). Here we report the identification of a novel published report report pathway for FAc and 4-FT biosynthesis from the actinomycetoma-causing 19 Feb 2014 pathogen Nocardia brasiliensis ATCC 700358. The new pathway shares overall conservation with the fl pathway in S. cattleya. Biochemical characterization of the conserved domains revealed a novel fluorinase 1 Changsheng Zhang, Chinese Academy of NobA that can biosynthesize 5’-fluoro-5’-deoxyadenosine (5’-FDA) from Sciences, Guangzhou, China inorganic fluoride and S-adenosyl-l-methionine (SAM). The NobA shows Cormac Murphy, University College Dublin, similar halide specificity and characteristics to the fluorination enzyme FlA 2 Dublin, Ireland of the fl pathway. Kinetic parameters for fluoride (Km 4153 μM, kcat 0.073 -1 -1 min ) and SAM (Km 416 μM, kcat 0.139 min ) have been determined, Any reports and responses or comments on the revealing that NobA is slightly (2.3 fold) slower than FlA.
    [Show full text]
  • Generated by SRI International Pathway Tools Version 25.0, Authors S
    Authors: Pallavi Subhraveti Ron Caspi Peter Midford Peter D Karp An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Ingrid Keseler Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_000190595Cyc: Cellulophaga lytica DSM 7489 Cellular Overview Connections between pathways are omitted for legibility. Anamika Kothari phosphate molybdate RS04350 RS08315 phosphate molybdate Macromolecule Modification tRNA-uridine 2-thiolation inosine 5'- Nucleoside and Nucleotide Degradation ditrans,octacis- a peptidoglycan with ditrans,octacis- a [bis(guanylyl an N-terminal- a [protein] and selenation (bacteria) phosphate guanosine ditrans,octacis- (4R)-4-hydroxy- an L-asparaginyl- an L-cysteinyl- Aminoacyl-tRNA Charging tRNA charging nucleotides undecaprenyldiphospho- (L-alanyl-γ-D-glutamyl- undecaprenyldiphospho- undecaprenyldiphospho- molybdopterin) cys L-methionyl-L- C-terminal glu degradation 2-oxoglutarate [tRNA Asn ] [tRNA Cys ] degradation III N-acetyl-(N-acetyl-β-D- L-lysyl-D-alanyl-D- N-acetyl-(N- N-acetyl-(N- cofactor cysteinyl-[protein] L-glutamate cys glucosaminyl)muramoyl- alanine) pentapeptide acetylglucosaminyl) acetylglucosaminyl) chaperone]- Phe IMP bifunctional phe a tRNA L-alanyl-γ-D-glutamyl-L-
    [Show full text]
  • Poster Abstracts
    ENGINEERING BACTERIAL NITROREDUCTASES FOR ANTICANCER GENE THERAPY AND TARGETED CELL ABLATION Abigail Sharrock, School of Biological Sciences, Victoria University of Wellington, NZ [email protected] Elsie Williams, Department of Chemistry, Emory University, USA Kelsi Hall, School of Biological Sciences, Victoria University of Wellington, NZ Jeff Mumm, Wilmer Eye Institute, Johns Hopkins University, USA David Ackerley, School of Biological Sciences, Victoria University of Wellington, NZ Key Words: nitroreductase, prodrug, directed evolution, gene therapy, cell ablation Bacterial nitroreductases are members of a diverse family of oxidoreductase enzymes that can catalyse the bioreductive activation of nitroaromatic compounds, including anti-cancer and antibiotic prodrugs. Nitroreductases have diverse applications in medicine and research, including anti-cancer gene therapy and targeted ablation of nitroreductase-expressing cells in transgenic zebrafish to model degenerative diseases. Research in these fields to date has focused almost exclusively on the canonical nitroreductase NfsB from Escherichia coli (NfsB_Ec), which is a relatively inefficient choice for most applications. By exploring alternative nitroreductase candidates from a variety of bacterial species, in concert with enzyme engineering to fine-tune specific activities, we have generated improved prodrug-activating enzymes. The nitroreductase NfsB from Vibrio vulnificus (NfsB_Vv) has been central to our efforts, and following solution of its crystal structure, was selected as a scaffold for directed evolution via site-saturation mutagenesis. By applying library screening strategies that involved rounds of both positive and negative selection, several mutants that displayed improved activity with a promising next-generation cancer prodrug were identified. In parallel work, an engineered NfsB_Vv variant from the same library was found to be substantially improved in activation of the antibiotic prodrug metronidazole, which is widely used for targeted cell ablation in transgenic zebrafish.
    [Show full text]
  • Enzymatic Defluorination of Fluorinated Compounds
    Seong et al. Appl Biol Chem (2019) 62:62 https://doi.org/10.1186/s13765-019-0469-6 INVITED REVIEW Open Access Enzymatic defuorination of fuorinated compounds Hyeon Jeong Seong†, Seong Woo Kwon†, Dong‑Cheol Seo, Jin‑Hyo Kim* and Yu‑Sin Jang* Abstract Fluorine‑containing compounds are widely used because they have properties required in textiles and coatings for electronic, automotive, and outdoor products. However, fuorinated compounds do not easily break down in nature, which has resulted in their accumulation in the environment as well as the human body. Recently, the enzymatic defuorination of fuorine‑containing compounds has gained increasing attention. Here, we review the enzymatic defuorination reactions of fuorinated compounds. Furthermore, we review the enzyme engineering strategies for cleaving C–F bonds, which have the highest dissociation energy found in organic compounds. Keywords: C–F bond, Defuorination, Fluorine, Perfuorinated compound Introduction and the corresponding enzymes, have not been well Because perfuorinated compounds (PFCs) repel both elucidated. water and oil, they are used as durable repellent treat- On the other hand, fuorinated compounds such as ments for textiles such as outdoor clothes and for home fuoroacetate and 5′-fuoro-5′-deoxyadenosine have been products such as carpets [1]. In addition, PFCs are widely identifed as natural products in nature [10, 11], dem- used in the production of fuoropolymers such as polyte- onstrating the existence of a biosynthesis pathway for trafuoroethylene (trade name, Tefon), which is widely fuorinated compounds in organisms [12]. A representa- used in coatings for electronic, automotive, and outdoor tive pathway of this type is the C–F bond forming reac- products [2].
    [Show full text]
  • Chemoenzymatic Enantioselective Synthesis
    TURUN YLIOPISTON JULKAISUJA ANNALES UNIVERSITATIS TURKUENSIS SARJA - SER. D OSA - TOM. 815 MEDICA - ODONTOLOGICA CHEMOENZYMATIC ENANTIOSELECTIVE SYNTHESIS OF b-AMINO ACID DERIVATIVES USING LIPASES by Xiang-Guo Li TURUN YLIOPISTO Turku 2008 Department of Pharmacology, Drug Development and Therapeutics/ Laboratory of Synthetic Drug Chemistry University of Turku Turku, Finland. Supervisor and custos: Professor Liisa T. Kanerva, Ph.D. Laboratory of Synthetic Drug Chemistry University of Turku Turku, Finland. Reviewers: Professor Ulf Hanefeld, Ph.D. Delft University of Technology Delft, The Netherlands and Professor Reko Leino, Ph.D. Åbo Academi University Turku, Finland Opponent: Professor Per Berglund, Ph.D. Royal Institute of Technology (KTH) Stockholm, Sweden ISBN 978-951-29-3671-7 (PRINT) ISBN 978-951-29-3672-4 (PDF) ISSN 0355-9483 Painosalama Oy – Turku, Finland 2008 CONTENTS Abstract Tiivistelmä (Abstract in Finnish) HAbbreviations HList of original papers H1 Introduction............................................................................................................................ H1 H2 Review of the literature .......................................................................................................... H3 H2.1 Kinetic resolution ........................................................................................................... H3 H2.2 Lipase catalysis .............................................................................................................. H5 H2.2.1 Lipases ...............................................................................................................
    [Show full text]
  • Organic & Biomolecular Chemistry
    Please do not adjust margins Organic & Biomolecular Chemistry Paper An enzymatic Finkelstein reaction: Fluorinase catalyses direct halogen exchange Received 00th January 20xx, Accepted 00th January 20xx Phillip T. Lowe,a Steven L. Cobbb and David O'Hagan*a DOI: 10.1039/x0xx00000x www.rsc.org/ The fluorinase enzyme from Streptomyces cattleya is shown to catalyse a direct displacement of bromide and iodide by fluoride ion from 5’-bromodeoxyadenosine (5’-BrDA) and 5’-iododeoxyadenosine (5’-IDA) respectively, to form 5’-fluorodeoxyadenosine (5’-FDA) in the absence of L-methionine (L-Met) or S-adenosyl- L-methionine (SAM). 5’-BrDA is the most efficient substrate for this enzyme catalysed Finkelstein reaction. Introduction 5’-chloro-5’-deoxy adenosine (5’-ClDA) 1 by L-Met to generate SAM Fluorine containing compounds have a remarkable record in tuning 2.15 When this reaction is conducted in the presence of fluoride ion, the properties of medicinal,1,2 agricultural3,4 and materials5 the resultant SAM 2 is then converted to 5’-FDA 3, to achieve a two- chemistry products. As such, in recent years the development of step transhalogenation from 5’-ClDA 1 to 5’-FDA 3. The substrate methodology to incorporate fluorine into biologically and flexibility of this ‘two-step’ fluorination process extends to 2’-deoxy commercially relevant compounds under mild conditions has analogues16 of 5’-ClDA 1 as well as C-2 decoration of the adenosine intensified. The naturally occurring fluorinase enzyme (5’-fluoro-5’- base of 5’-ClDA 1 with an acetylene, or terminally functionalised deoxy-adenosine synthase), originally isolated from Streptomyces acetylene moieties.17-23 In this manner, fluorinase-mediated trans- cattleya where it is involved in the C-F bond forming step in halogenation reactions have become established as a strategy for the fluoroacetate and 4-fluorothreonine biosynthesis, offers a rare synthesis of fluorinated bioactive compounds under experimentally opportunity to introduce fluorine enzymatically.
    [Show full text]
  • Generated by SRI International Pathway Tools Version 25.0, Authors S
    Authors: Pallavi Subhraveti Ron Caspi Peter Midford Peter D Karp An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Ingrid Keseler Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_000299235Cyc: Leptospirillum ferriphilum ML-04 Cellular Overview Connections between pathways are omitted for legibility. Anamika Kothari phosphate phosphate phosphate phosphate ammonium ammonium ammonium predicted ABC transporter RS12230 RS11960 RS10935 RS01775 RS01785 RS04585 of phosphate phosphate phosphate phosphate ammonium ammonium ammonium phosphate Macromolecule Modification Inorganic Nutrient Metabolism tRNA-uridine 2-thiolation UDP-N-acetyl- undecaprenyl- a carboxy- a nascent a peptidoglycan an [amino-group β 34 a nucleoside cob(II)yrinate a,c- Cofactor, Carrier, and Vitamin Biosynthesis selenate reduction α-D-glucosamine diphospho-N- adenylated- peptidoglycan a uracil in DNA D-glycero- -D- a cytidine lys dimer (meso- met carrier protein]- [2Fe-2S] iron-sulfur thioredoxin flavin biosynthesis I (bacteria and plants) lipoate biosynthesis lipoate salvage I benzimidazolyl adenosylcobamide lipoate biosynthesis pyridoxal 5'-phosphate biosynthesis I folate transformations III (E. coli) Fatty Acid and
    [Show full text]
  • Natural Production of Fluorinated Compounds and Biotechnological Prospects of the Fluorinase Enzyme
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Repositório Científico do Instituto Politécnico do Porto Natural production of fluorinated compounds and biotechnological prospects of the fluorinase enzyme a b,c Maria F. Carvalho and Rui S. Oliveira aCIIMAR – Interdisciplinary Centre of Marine and Environmental Research, University of Porto, Porto, Portugal; bCentre for Functional Ecology, Department of Life Sciences, University of Coimbra, Coimbra, Portugal; cDepartment of Environmental Health, Research Centre on Health and Environment, School of Allied Health Sciences, Polytechnic Institute of Porto, Porto, Portugal ABSTRACT Fluorinated compounds are finding increasing uses in several applications. They are employed in almost all areas of modern society. These compounds are all produced by chemical synthesis and their abundance highly contrasts with fluorinated molecules of natural origin. To date, only some plants and a handful of actinomycetes species are known to produce a small number of fluori- nated compounds that include fluoroacetate (FA), some x-fluorinated fatty acids, nucleocidin, 4-fluorothreonine (4-FT), and the more recently identified (2R3S4S)-5-fluoro-2,3,4-trihydroxypenta- noic acid. This largely differs from other naturally produced halogenated compounds, which totals more than 5000. The mechanisms underlying biological fluorination have been uncovered after discovering the first actinomycete species, Streptomyces cattleya, that is capable of produc- ing FA and 4-FT, and a fluorinase has been identified as the enzyme responsible for the forma- tion of the C–F bond. The discovery of this enzyme has opened new perspectives for the biotechnological production of fluorinated compounds and many advancements have been achieved in its application mainly as a biocatalyst for the synthesis of [18F]-labeled radiotracers for medical imaging.
    [Show full text]
  • A Localised Tolerance in the Substrate Specificity of the Fluorinase Enables ‘Last Step’ [18F]-Fluorination of a RGD Peptide Under Ambient Aqueous Conditions
    A localised tolerance in the substrate specificity of the fluorinase enables ‘last step’ [18F]-fluorination of a RGD peptide under ambient aqueous conditions Stephen Thompsona, Qingzhi Zhanga, Mayca Onegab, Stephen McMahona, Ian Flemingc, Sharon Ashworth,b James H. Naismitha, Jan Passchierb, David O’Hagana*. aSchool of Chemistry, University of St Andrews, North Haugh, St Andrews, KY16 9ST, UK. bImanova, Burlington Danes Building, Imperial College London, Hammersmith Hospital, Du Cane Road, London,W12 0NN, UK cAberdeen Biomedical Imaging Centre, School of Medicine and Dentistry, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK. dImperial College London, Departent of Medicine, Burlington Danes Building, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN (United Kingdom) ǂAuthors contributed equally. Abstract: A strategy for last step [18F]-fluorination of bioconjugated peptides is reported that exploits an ‘Achilles heel’ in the substrate specificity of the fluorinase enzyme. An acetylene functionality at C-2 of the adenosine substrate projects from the active site into the solvent. The fluorinase catalyses a transhalogenation of 5’-chlorodeoxy-2-ethynyladenosine (ClDEA) to 5’-fluorodeoxy-2-ethynyladenosine [18F]-FDEA. Extending a polyethelene glycol linker from the terminus of the acetylene allows bio- conjugation cargo to be presented to the enzyme for [18F]-labeling. The method benefits from using an 18 18 aqueous (H2 O) solution of [ F]-fluoride, generated by the cyclotron and has the modular capacity
    [Show full text]